Found: 37
Select item for more details and to access through your institution.
Vδ2 T-cell engagers bivalent for Vδ2-TCR binding provide anti-tumor immunity and support robust Vγ9Vδ2 T-cell expansion.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1474007
- By:
- Publication type:
- Article
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1096, doi. 10.3390/ijms22031096
- By:
- Publication type:
- Article
Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 2, p. 326, doi. 10.3390/jcm9020326
- By:
- Publication type:
- Article
Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 6, p. 819, doi. 10.3390/jcm8060819
- By:
- Publication type:
- Article
Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 143, doi. 10.3390/jcm8020143
- By:
- Publication type:
- Article
Systemic Capillary Leak Syndrome (Clarkson Syndrome) in Cancer Patients: A Systematic Review.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 11, p. 418, doi. 10.3390/jcm7110418
- By:
- Publication type:
- Article
Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8 + T Cell Responses via CD169 + Macrophages and cDC1.
- Published in:
- Vaccines, 2021, v. 9, n. 1, p. 56, doi. 10.3390/vaccines9010056
- By:
- Publication type:
- Article
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.915837
- By:
- Publication type:
- Article
Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 9, p. 2681, doi. 10.1245/s10434-018-6567-6
- By:
- Publication type:
- Article
Immunological effects of everolimus in patients with metastatic renal cell cancer.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2017, v. 30, n. 4, p. 341, doi. 10.1177/0394632017734459
- By:
- Publication type:
- Article
Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function.
- Published in:
- Scientific Reports, 2017, p. 43873, doi. 10.1038/srep43873
- By:
- Publication type:
- Article
Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02606
- By:
- Publication type:
- Article
CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01519
- By:
- Publication type:
- Article
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 787, doi. 10.1007/s00262-019-02313-z
- By:
- Publication type:
- Article
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 503, doi. 10.1007/s00262-018-2288-8
- By:
- Publication type:
- Article
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 319, doi. 10.1007/s00262-018-2248-3
- By:
- Publication type:
- Article
Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5612, doi. 10.3390/cancers14225612
- By:
- Publication type:
- Article
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5446, doi. 10.3390/cancers13215446
- By:
- Publication type:
- Article
Pancreatic Cancer and Immunotherapy: A Clinical Overview.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4138, doi. 10.3390/cancers13164138
- By:
- Publication type:
- Article
Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3902, doi. 10.3390/cancers13153902
- By:
- Publication type:
- Article
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 711, doi. 10.3390/cancers13040711
- By:
- Publication type:
- Article
Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1798, doi. 10.3390/cancers11111798
- By:
- Publication type:
- Article
Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1801, doi. 10.3390/cancers11111801
- By:
- Publication type:
- Article
Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1699, doi. 10.3390/cancers11111699
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor as Target for Perioperative Elimination of Circulating Colorectal Cancer Cells.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/3577928
- By:
- Publication type:
- Article
Proceedings From the First International Workshop at Sidra Medicine: "Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development", 15<sup>th</sup>–16<sup>th</sup> February 2019, Doha, Qatar.
- Published in:
- Frontiers in Immunology, 2021, p. N.PAG, doi. 10.3389/fimmu.2020.589381
- By:
- Publication type:
- Article
A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
- Published in:
- 2019
- By:
- Publication type:
- journal article
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00631
- By:
- Publication type:
- Article
In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer.
- Published in:
- Frontiers in Immunology, 2017, v. 8, p. 1, doi. 10.3389/fimmu.2017.00087
- By:
- Publication type:
- Article
Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 5, p. 581, doi. 10.3390/pharmaceutics16050581
- By:
- Publication type:
- Article
Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0157830
- By:
- Publication type:
- Article
IPEX as a Result of Mutations in FOXP3.
- Published in:
- Clinical & Developmental Immunology, 2007, p. 1, doi. 10.1155/2007/89017
- By:
- Publication type:
- Article
Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1135, doi. 10.1634/theoncologist.2018-0263
- By:
- Publication type:
- Article
Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Optimal treatment of opioid induced constipation in daily clinical practice – an observational study.
- Published in:
- BMC Palliative Care, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12904-019-0416-7
- By:
- Publication type:
- Article